36 filings
6-K
BNR
Burning Rock Biotech Ltd
28 Mar 24
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
5:25pm
6-K
BNR
Burning Rock Biotech Ltd
4 Jan 24
Burning Rock Announces Receipt of Notification from NASDAQ
6:01am
6-K
BNR
Burning Rock Biotech Ltd
20 Dec 23
Burning Rock Announces Results of 2023 Annual General Meeting
6:09am
6-K
BNR
Burning Rock Biotech Ltd
30 Nov 23
Burning Rock Reports Third Quarter 2023 Financial Results
6:08am
6-K
BNR
Burning Rock Biotech Ltd
22 Nov 23
Current report (foreign)
6:08am
6-K
se5p dlqkhh3mv1isx29
5 Sep 23
Burning Rock Reports Second Quarter 2023 Financial Results
6:09am
6-K
ujeo6nr4p7
28 Jun 23
Burning Rock Announces Resignation and Appointment of Directors
6:18am
6-K
itqqdg1b6w1
30 May 23
Burning Rock Reports First Quarter 2023 Financial Results
6:18am
6-K
802e1
20 Apr 23
Current report (foreign)
4:06pm
6-K
n131v fwc29ntbxg
28 Mar 23
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
7:31am
6-K
emxa6mva 2u8
18 Jan 23
Burning Rock provides an update on 2022 revenue guidance
6:06am
6-K
03ndjmqy
4 Jan 23
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
6:08am
6-K
752j au3l
16 Nov 22
Burning Rock Reports Third Quarter 2022 Financial Results
6:07am
6-K
6r1cj5o8sv
7 Nov 22
Current report (foreign)
4:10pm
6-K
niv 5j3h97fj1smphp0
7 Nov 22
Current report (foreign)
4:06pm
6-K
dhav6 k26gvmxda24f25
7 Nov 22
Management’s Discussion and Analysis of Financial Condition and Results of Operations
7:32am
6-K
vhhljoh4ils59sctbk
2 Nov 22
BURNING ROCK BIOTECH LIMITED – Admission to Trading on the London Stock Exchange
6:14am
6-K
05vt 1sogc7
27 Oct 22
BURNING ROCK BIOTECH LIMITED – Approval and Publication of Prospectus
4:07pm
6-K
v0ow whhzlpuz5k3c
21 Oct 22
BURNING ROCK BIOTECH LIMITED – Proposed Direct Listing on the London Stock Exchange and Publication of Registration Document
4:09pm
6-K
yap9o6 wtb7
8 Sep 22
Burning Rock Announces Results of 2022 Annual General Meeting
6:20am